The pharmacotherapy of the HeartMate II, a continuous flow left ventricular assist device, in patients with advanced heart failure: Integration of disease, device, and drug

Annals of Pharmacotherapy

Volumn 44, Issue 10, 2010, Pages 1647-1650

  Jennings, Douglas L ^a   Chambers, Rachel M ^a   Schillig, Jessica M ^a  

^a HENRY FORD HOSPITAL   (United States)

Author keywords

Anticoagulation; Heart failure; Left ventricular assist device; Pharmacotherapy

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPYRIDAMOLE; FLUCONAZOLE; HEPARIN; HYDRALAZINE; LEVOFLOXACIN; MILRINONE; NITRIC OXIDE; RIFAMPICIN; SILDENAFIL; TROVAFLOXACIN; VANCOMYCIN; WARFARIN;

ANTICOAGULANT THERAPY; ANTICOAGULATION; CARDIOVERSION; DEVICE INFECTION; DRUG EFFICACY; DRUG WITHDRAWAL; ENTEROCOCCUS; FOOD AND DRUG ADMINISTRATION; GASTROINTESTINAL HEMORRHAGE; HEART AFTERLOAD; HEART ASSIST DEVICE; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART LEFT VENTRICLE; HEART PRELOAD; HEART RIGHT VENTRICLE FAILURE; HEART RIGHT VENTRICLE FUNCTION; HEART SURGERY; HEART VENTRICLE ARRHYTHMIA; HUMAN; INFECTION PREVENTION; INTERNATIONAL NORMALIZED RATIO; MEAN ARTERIAL PRESSURE; NOTE; PARTIAL THROMBOPLASTIN TIME; PHARMACIST; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; PROGNOSIS; STAPHYLOCOCCUS AUREUS; SYSTEMIC VASCULAR RESISTANCE; THERAPY EFFECT; THROMBOEMBOLISM; THROMBOSIS; THROMBUS; TREATMENT RESPONSE;

ANTI-INFECTIVE AGENTS; ANTICOAGULANTS; HEART FAILURE; HEART TRANSPLANTATION; HEART-ASSIST DEVICES; HUMANS; PATIENT EDUCATION AS TOPIC; PHARMACEUTICAL SERVICES; PHARMACISTS; POSTOPERATIVE COMPLICATIONS; PROFESSIONAL ROLE; PROSTHESIS IMPLANTATION; PROSTHESIS-RELATED INFECTIONS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 77957653902     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1P340     Document Type: Note

References (15)

1. Lloyd-Jones D, Adams RJ, Brown TM, et al., on behalf of the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics - 2010 update: a report from the American Heart Association. Circulation 2010;121:e46-215.
2. Hunt SA, Abraham WT, Chin MH, et al. 2009 Focused update incorporated into the ACC/AHA 2005 guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2009;53:e1-90.
3. Slaughter MS, Rogers JG, Milano CA, et al. Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med 2009;361:2241-51.
4. Thoratec Corporation press release, January 20, 2010. www.thoratec.com (accessed 2010 Apr 21).
5. Drakos SG, Janicki L, Horne BD, et al. Risk factors predictive of right ventricular failure after left ventricular assist device implantation. Am J Cardiol 2010;105:1030-5.
6. Martinez EA, Bass EB, Zimetbaum P. American College of Chest Physicians guidelines for the prevention and management of postoperative atrial fibrillation after cardiac surgery. Chest 2005;128:48S-55S.
7. Boyle AJ, Russell SD, Teuteberg JJ, et al. Low thromboembolism and pump thrombosis with the HeartMate II left ventricular assist device: analysis of outpatient anticoagulation. J Heart Lung Transplant 2009;28:881-7.
8. Frazier OH, Gemmato C, Myers TJ, et al. Initial clinical experience with the HeartMate II axial-flow left ventricular assist device. Tex Heart Inst J 2007;34:275-81.
9. John R, Kamdar F, Liao K, et al. Low thromboembolic risk for patients with the HeartMate II left ventricular assist device. J Thorac Cardiovasc Surg 2008;136:1318-23.
10. Slaughter MS, Pagani FD, Rogers JG, et al. Clinical management of continuous-flow left ventricular assist devices in advanced heart failure. J Heart Lung Transplant 2010;29:S1-39.
11. Kirklin JK, Naftel DC, Kormos RL, et al. Second INTERMACS annual report: more than 1,000 primary left ventricular assist device implants. J Heart Lung Transplant 2010;29:1-10.
12. Gordon RJ, Quagliarello B, Lowy FD. Ventricular assist device-related infections. Lancet Infect Dis 2006;6:426-37.
13. Holman WL, Park SJ, Long JW, et al. Infection in permanent circulatory support: experience from the REMATCH trial. J Heart Lung Transplant 2004;23:1359-65.
14. Eyler RF, Butler SO, Walker PC, DePestel DD, Spoor MT, et al. Vancomycin use during left ventricular assist device support. Infect Control Hosp Epidemiol 2009;30:484-6.
15. Arrecubieta C, Asai T, Bayern M, et al. The role of Staphylococcus aureus adhesions in the pathogenesis of ventricular assist device-related infections. J Infect Dis 2006;193:1109-19.